Journal article icon

Journal article

Immunomodulatory therapy to achieve maximum efficacy: doses, monitoring, compliance, and self-infusion at home.

Abstract:

INTRODUCTION: The Oxford Programme for Immunomodulatory Immunoglobulin Therapy has been operating since 1992 at Oxford Radcliffe Hospitals in the UK. Initially, this program was set up for patients with multifocal motor neuropathy or chronic inflammatory demyelinating poly-neuropathy to receive reduced doses of intravenous immunoglobulin (IVIG) in clinic on a regular basis (usually every 3 weeks). The program then rapidly expanded to include self-infusion at home, which monitoring showed to ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1007/s10875-010-9400-y

Authors


Expand authors...
Journal:
Journal of clinical immunology
Volume:
30 Suppl 1
Issue:
SUPPL. 1
Pages:
S84-S89
Publication date:
2010-05-05
DOI:
EISSN:
1573-2592
ISSN:
0271-9142
URN:
uuid:5f16698d-a1b6-4456-b4b1-cc8d67d2eab5
Source identifiers:
66509
Local pid:
pubs:66509

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP